Page 12

2026-09-03 · 2026-09 / week-1

C3.ai prices a turnaround before the cash bridge proves it

Summary: U.S. short Watchlist, reject for current execution. C3.ai, Inc. NYSE: AI reported $2.072 million of positive operating cash flow and free cash flow for fiscal Q1 2027, but the same release shows a $98.268 millio...

2026-09-03 · 2026-09 / week-1

ChargePoint's 19% after-hours rally still owes the cash bridge

Summary: U.S. short Watchlist, reject for current execution. ChargePoint Holdings, Inc. NYSE: CHPT was shown at $6.13 in an after-hours market-data snapshot at 2026-09-02 21:21:00 UTC, up 18.11% from the $5.19 regular-se...

2026-09-02 · 2026-09 / week-1

PMV's $50.8M financing creates supply, not a clean short

Summary: U.S. short Watchlist, reject for current execution. PMV Pharmaceuticals, Inc. Nasdaq: PMVP was quoted at $1.2600 in a live market-data snapshot at 2026-09-02 15:18:57 UTC, down 2.32558%, with an intraday range o...

2026-09-02 · 2026-09 / week-1

Stardust Power's $35M Nasdaq test is not a refinery funding plan

Summary: U.S. short Watchlist, reject for current execution. Stardust Power Inc. Nasdaq: SDST was quoted at $0.2890 in a live market-data snapshot at 2026-09-02 13:59:56 UTC, down 17.45216%, with a reported $0.2870 to $0...

2026-09-01 · 2026-09 / week-1

Asana prices slow seats, but RPO and cash need to hold

Summary: U.S. long Watchlist. Asana, Inc. NYSE: ASAN traded at $10.13 in the live finance snapshot at 2026-09-01 14:41:05 UTC, down 1.27% from the provider's prior close. This is a regular-session context quote, not a ve...

2026-09-01 · 2026-09 / week-1

Cadrenal's FDA alignment is not a funded Phase 3

Summary: U.S. short Watchlist. Cadrenal Therapeutics Nasdaq: CVKD closed at $1.75 on Aug. 31 after announcing that the FDA had aligned with the company on the primary endpoint, statistical analysis plan, and placebo desi...

2026-08-31 · 2026-08 / week-5

Rezolve's $127 million H1 headline still owes the cash bridge

Summary: U.S. short Watchlist. Rezolve Ai Nasdaq: RZLV traded at $2.83 at 2026-08-31 14:22:48 UTC, down 4.71380%, with 12,670,419 shares reported in the live finance-feed context. The stock had closed at $2.96 on Aug. 25...